@TeamImugene Allogene is showing why they are the front runner while IMU is on the brink of collapse. Needed a deal months ago, clearly the data isn’t good enough.
@TeamImugene Can’t wait for another webinar, with LC & PH gaslighting SH’s with “we don’t know why the SP has tanked”. Zero accountability.
Serious red flag for anyone looking at IMU to consider that management are incredibly disconnected with the market.
@TeamImugene Unfortunately it’s starting to feel like the beginning of the end. 6-months well past the expiry of a much needed funding deal. Doesn’t appear anything is on the horizon, SP tanking as a result. A CR just around the corner to kick the can for another 6-months
@TeamImugene@Forbes Wow still paying for articles. Clearly haven’t learnt that does not work. PH really trying to pump his tyres on his failing companies.
@ColinShardlow@TeamImugene It will be shelved likely with no further updates. An incredible amount of cash spent on it to be shelved with the other programs. Lucky John pulled a cat out of the bag with Azer Cel. If not, the SP would be 1c (post consolidation).
@TeamImugene Joke of a company. More shelved programs after spending hundreds of millions of cash. Last shot at goal with Azer Cel. Here is to another year of blown out timelines, burnt cash and shareholder wealth decimation.
@CmAkmKk@TeamImugene Nah not yet. They said all directors will participate. If they came out prior and said they have all participated X amount, might have given retail more confidence to participate.
@jomaaib@Scotty865534283@TeamImugene In the next 6 months, my guess is IMU will either be:
1. 10c as IMU will roll into the next CR.
2. $1 as IMU landed a deal to provide funding assistance for the Rego Trial.
Hard to see much in between
@CmAkmKk@TeamImugene Correct. Weird way to promote Azer Cel, but any coverage is better than nothing. Would be nice if they have an interview with someone that actually benefited directly from Azer Cel and could share their experience.
@Scotty865534283@jomaaib@TeamImugene My guess is they will need to before the end of Q1 unless they drastically reduce spending. ~2.5 years until the completion of a registrational trial. Just consider the amount of dilution that is to come if they don’t land a funding deal very soon.